Cargando…

Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial

OBJECTIVE: We evaluated whether the increasing number of genetic loci for coronary artery disease (CAD) identified in the general population could be used to predict the risk of major CAD events (MCE) among participants with type 2 diabetes at high cardiovascular risk. RESEARCH DESIGN AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morieri, Mario Luca, Gao, He, Pigeyre, Marie, Shah, Hetal S., Sjaarda, Jennifer, Mendonca, Christine, Hastings, Timothy, Buranasupkajorn, Patinut, Motsinger-Reif, Alison A., Rotroff, Daniel M., Sigal, Ronald J., Marcovina, Santica M., Kraft, Peter, Buse, John B., Wagner, Michael J., Gerstein, Hertzel C., Mychaleckyj, Josyf C., Parè, Guillaume, Doria, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196830/ https://www.ncbi.nlm.nih.gov/pubmed/30262460 http://dx.doi.org/10.2337/dc18-0709

Ejemplares similares

Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD
por: Shah, Hetal S., et al.
Publicado: (2018)

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial
por: Shah, Hetal S., et al.
Publicado: (2016)

PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid
por: Morieri, Mario Luca, et al.
Publicado: (2020)

A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment
por: Mariam, Arshiya, et al.
Publicado: (2021)

Reversibility of Fenofibrate Therapy–Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants
por: Mychaleckyj, Josyf C., et al.
Publicado: (2012)

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies
por: Tang, Yaling, et al.
Publicado: (2019)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes
por: Prudente, Sabrina, et al.
Publicado: (2015)

Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008)

Buffy coat specimens remain viable as a DNA source for highly multiplexed genome-wide genetic tests after long term storage
por: Mychaleckyj, Josyf C, et al.
Publicado: (2011)

Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial
por: Marvel, Skylar W., et al.
Publicado: (2017)

Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
por: Mohammadi-Shemirani, Pedrum, et al.
Publicado: (2020)

Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
por: West, Nancy A., et al.
Publicado: (2009)

Embracing Integrative Multiomics Approaches
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Hypokalemic Periodic Paralysis as the First Manifestation of Thyrotropin-Secreting Pituitary Adenoma
por: Kaewkrasaesin, Chatchon, et al.
Publicado: (2019)

Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study
por: Shah, Amy S., et al.
Publicado: (2017)

Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial
por: Cukierman-Yaffe, Tali, et al.
Publicado: (2009)

Gene set analysis methods: a systematic comparison
por: Mathur, Ravi, et al.
Publicado: (2018)

Clinical characteristics and treatment outcomes in acromegaly, a retrospective single-center case series from Thailand
por: Ganokroj, Poranee, et al.
Publicado: (2021)

Cheminformatics approach to exploring and modeling trait-associated metabolite profiles
por: Ash, Jeremy R., et al.
Publicado: (2019)

When to start paediatric testing of the adult HIV cure research agenda?
por: Shah, Seema K
Publicado: (2017)

Risk and radical uncertainty in HIV research
por: Hare, Caspar
Publicado: (2017)

Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk: A 2-Sample Mendelian Randomization Study
por: Sood, Tushar, et al.
Publicado: (2023)

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
por: Charytan, David M, et al.
Publicado: (2023)

Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response
por: Graham, Hillary T., et al.
Publicado: (2016)

Association of osteoporosis and sarcopenia with fracture risk in transfusion-dependent thalassemia
por: Thavonlun, Suttana, et al.
Publicado: (2023)

Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort: Rapid kidney function decline and heart failure in T2D
por: Bueno Junior, Carlos Roberto, et al.
Publicado: (2023)

Use of an electronic health record to identify prevalent and incident cardiovascular disease in type 2 diabetes according to treatment strategy
por: Korytkowski, Mary T, et al.
Publicado: (2016)

Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis
por: Cardona, Andrea, et al.
Publicado: (2019)

Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Association of sexual dysfunction according to DSM-5 diagnostic criteria with avoidance of and discomfort during sex in a population-based sample
por: Koops, Thula U, et al.
Publicado: (2023)

Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study
por: Wang, Tiange, et al.
Publicado: (2022)

Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort
por: Fu, Liyao, et al.
Publicado: (2022)

Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study
por: Anjana, Ranjit Mohan, et al.
Publicado: (2020)

Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
por: Basu, Sanjay, et al.
Publicado: (2018)

Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial(1)(2)
por: Hazim, Sara, et al.
Publicado: (2016)

The AGMK1-9T7 cell model of neoplasia: Evolution of DNA copy-number aberrations and miRNA expression during transition from normal to metastatic cancer cells
por: Lewis, Andrew M., et al.
Publicado: (2022)

Identifying individual risk rare variants using protein structure guided local tests (POINT)
por: Marceau West, Rachel, et al.
Publicado: (2019)

Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?
por: Sohani, Zahra N., et al.
Publicado: (2014)

Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial
por: Gerstein, Hertzel C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gkoqon7mnaehgqm4cceq6cb6nb